Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letetresgene autoleucel in advanced myxoid/round cell liposarcoma
NCT02992743Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2016
- Primary completion
- Nov 2021
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of letetresgene autoleucel in myxoid liposarcoma (MLPS), myxoid/round cell liposarcoma (MRCLS), sponsored by GSK. Started Dec 2016; status: completed.
02
Drugs
letetresgene autoleucel
03
Conditions
myxoid liposarcoma (MLPS)myxoid/round cell liposarcoma (MRCLS)
Beyond the preview
Go deeper on NCT02992743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02992743.